Nasdaq · Biotech stocks database

RGEN — Repligen Corporation

RGEN (Repligen Corporation) stock: $181.38, $8.87B market cap, $810.4M cash, $8.61B EV, $10.77B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

Share price

$181.38

Market cap

$8,874.0M

Cash

$810.4M

Enterprise value

$8,614.6M

Balance sheet

Cash	$810.4M
Debt	$551.0M
Net cash	$259.4M
Enterprise value	$8,614.6M
Basic shares	56.4M shares
Fully diluted shares	59.4M shares
Fully diluted market cap	$10,772.2M
Cash per share	$14.37

Cash figures as of 2026-06-30. Database snapshot: 2026-09-22.

Price history

Loading RGEN daily closes…

Loading price history…

Institutional holders

Fund	Shares	Q/Q change	% of portfolio	Filing
Braidwell LP	16,177,100	-84,870,400	1.50%	2026-08-14
RTW Investments	1,240,637	+34,637	1.45%	2026-08-14

Institutional holder positions from 13F filings. Q/Q change is vs the prior quarter's filing; % of portfolio is the fund's own reported portfolio weight.

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 714 stocks.

Subscribe to Compounding Ego